With the increasing number of accurate medical- related analytical methods for cancer, the continuous development of new analytical tools will not only be limited to the analysis method itself, but also focus on improving the user interaction experience, "one-stop" and other comprehensive services, targeting the patient's specific situation. The specific analysis aims to provide the most comprehensive and accurate analysis service without requiring users to have any ability to interpret biological information. Recently, researchers from the Columbia University Medical Center have developed a set of precision treatments, iCAGES, that can quickly compare and screen related cancer genes and search for and suggest these genes. This is not only the most comprehensive information available in the same type of analysis tool, but also the first analysis tool to provide a clean user interface. Most cancers are derived from the accumulation of somatic mutations, not a single gene mutation. On the other hand, large-scale sequencing projects for cancer patients to date have found that many mutations play a role in the development of many different cancers. However, these mutational information does not provide any specific information on cancer screening at the individual level: mutations that actually cause cancer may differ from each other, and some mutations thought to be involved may have no significant effect on a person. At present, no clinically used analytical tool can predict cancer-related mutations at the individual level. “Even even if the doctor knows the genes that cause cancer in the patient, it is not easy to choose the most suitable one from the hundreds of possible drug therapies,†said Dr. Wang Kai, the development leader of the tool. Speaking of it. Guangzhou Zhongzhinan Supply Chain Co.,Ltd. , https://www.gzzhongzhinan.com
Columbia University develops iCAGES, an accurate medical analysis tool for cancer treatment